Trump backed off his threat to obliterate Iran’s energy infrastructure and claims negotiations are underway. Here’s the ...
HIGHLIGHTS Formal centralized and independent analysis of the clinical response data from the ACCENT trial has been ...
Key combination for the treatment of first-line AMLRecent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with iadademstat in combination with venetoclax and ...